Boston's longer DES (drug-eluting stent) shelf life:
This article was originally published in Clinica
Executive Summary
The US FDA has given Boston Scientific the all-clear to extend the shelf life of its Taxus Express2 paclitaxel-eluting coronary stent from 12 months to 18 months. Boston noted that its extended shelf life is three times longer in the US than that for rival US drug-eluting stent (DES) Cypher, made by Johnson & Johnson. An extended shelf life may help facilitate inventory management for hospitals concerned with product expiration of DESs. Taxus' shelf life outside the US remains unchanged at 18 months.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.